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AbsTrACT
Objective Femtosecond laser-assisted cataract surgery 
(FLACS) decreases the use of energy and provides a more 
precise capsulorhexis compared with conventional phaco 
surgery (CPS). The purpose of this study was to examine if 
the lower energy use in FLACS caused less endothelial cell 
loss compared with CPS and if there was a difference in 
refractive predictability between CPS and FLACS.
Methods and analysis This was a randomised 
controlled study of 96 patients with a 6-month follow-up 
comparing one eye surgery by FLACS and the contralateral 
eye operated by CPS (divide and conquer technique). 
Both eyes had intraocular aspheric lenses implanted. 
Uncorrected distance visual acuity, corrected distance 
visual acuity (CDVA), central corneal endothelial cell count 
and hexagonality (non-contact endothelial cell microscope) 
were assessed preoperatively at 40 and at 180 days 
postoperatively.
results The mean phaco energies were 6.55 (95% 
CI 5.43 to 7.66) and 9.77 (95% CI 8.55 to 10.95) U/S 
(p<0.0001) by FLACS and CPS, respectively. At day 40, 
the mean endothelial cell loss (ECL) was 344 cells/mm2 
(95% CI 245 to 443) by FLACS (12.89%) and 497 cells/
mm2 (95% CI 380 to 614) by CPS (18.19%) (p=0.027). At 
day 180, ECL was 362 cells/mm2 (95% CI 275 to 450) in 
FLACS (13.56%) and 465 cells/mm2 (95% CI 377 to 554) in 
CPS (17.03%) (p=0.036).
The mean absolute difference from the attempted 
refraction was 0.43 (95% CI 0.36 to 0.51) dioptres (D) at 
day 40 and 0.46 D (95% CI 0.39 to 0.53) at day 180 by 
FLACS compared with 0.43 D (95% CI 0.36 to 0.51) at day 
40 (p=0.95) and 0.46 D (95% CI 0.37 to 0.52) at day 180 
(p=0.91) with CPS.
Conclusion ECL was significantly lower in FLACS 
compared with CPS at both day 40 and day 180. ECL was 
correlated to the energy used. We found no difference in 
refractive predictability or CDVA between the groups.
InTrOduCTIOn
Femtosecond laser-assisted cataract surgery 
(FLACS, see table 1 for abbreviations) was 
introduced in 2009 by Nagy et al.1 This tech-
nology provides a high-resolution anterior 
segment imaging system with a femtosecond 
laser, which delivers short pulses (10−15 s) of 
energy at a near-infrared wavelength, with 
the ability to focus at very specific depths 
within the anterior chamber. FLACS offers 
numerous potential advantages over conven-
tional phaco surgery (CPS) as FLACS can 
perform automated, standardised corneal 
incisions, capsulorhexis and lens fragmenta-
tion. Studies have shown that FLACS leads 
to more accurate capsulorhexis with less 
intraocular lens (IOL) decentration and lens 
Key messages
What is already known about this subject?
Femtosecond laser-assisted cataract surgery (FLACS) 
reduces effective phacoemulsification time (EPT) and 
cumulative dissipated energy (CDE) usage and can 
perform a consistent capsulotomy. This study examined 
if the lower EPT and CDE usage caused less endothelial 
cell loss (ECL) on the long term and if the consistent 
capsulotomy resulted in better refractive outcome 
compared with conventional phaco surgery (CPS).
What are the new findings?
FLACS caused 21% less ECL compared with CPS. The 
cell loss difference was 103 cells/mm2 at 6 months. 
In our study, FLACS did not provide superior refractive 
predictability nor better visual outcome than CPS.
How might these results change the focus of 
research or clinical practice?
A patient with a healthy endothelium can endure the 
cell loss difference found in this study. These results 
indicate that FLACS is not superior to CPS in patients 
with healthy eyes and therefore it should not be chosen 
over CPS.
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Table 1 List of abbreviations used in the article
Abbreviations
FLACS Femtosecond laser-assisted cataract 
surgery
CPS Conventional phaco surgery
ECD Endothelial cell density
ECL Endothelial cell loss
CDVA Corrected distance visual acuity
UDVA Uncorrected distance visual acuity
SE Spherical equivalent
MAE Mean absolute error
CDE Cumulative dissipated energy
tilt compared with manually performed capsulorhexis 
in CPS.2–5 A precise capsulotomy has been proposed 
to improve the precision of the IOL position, and thus 
the predictability of both IOL power and refractive 
outcome.6 7 The corneal endothelium maintains the trans-
parency of the cornea, thereby having an important role 
in maintaining a good visual outcome. It is well-known 
that phacoemulsification energy causes endothelial cell 
loss (ECL).8 Studies have shown that FLACS decreases 
endothelial cell loss compared with CPS. However, most 
studies have short-term follow-up and, therefore, the 
long-term effects of FLACS on the endothelium remains 
unknown.9–12 The purpose of this study was therefore to 
examine if FLACS is superior to CPS regarding refractive 
results and if the lower needed phaco energy in FLACS 
causes less ECL compared with CPS on the long term.
MATerIAls And MeTHOds
This prospective randomised clinical trial consists of 
a consecutive cohort of 108 patients that were offered 
FLACS on one eye and CPS on the contralateral eye at 
the Department of Ophthalmology, Glostrup, University 
Hospital of Copenhagen, Denmark.
All patients volunteered to be included in the trial.
Inclusion criteria were a visually significant cataract of 
any type and degree and age older than 18 years. Exclu-
sion criteria were a history of severe dry eye, corneal scars, 
history of herpetic keratitis, signs of keratoconus, history 
of uveitis, pseudoexfoliation syndrome, uncontrolled 
glaucoma, visually significant maculopathy, vitreomac-
ular traction, lack of cooperation or tremor and previous 
ocular surgery. If patients failed to have both eyes oper-
ated on (one eye with FLACS and the other eye with 
standard CPS), they were also excluded.
Preoperatively
The patients underwent an assessment to establish eligi-
bility for undergoing FLACS and CPS.
All patients were used as their own control, and the 
following measurements were done: corrected distance 
visual acuity (CDVA) using an LCD visual acuity chart 
with equal logarithmic difference between the lines 
with decimal numbers for later possible conversion to 
logMAR values, autorefraction, IOL power calculation by 
the SRK/T formula in axial length 22–28 mm and Haigis 
formula in axial length <22 or >28 mm (IOLMaster; Carl 
Zeiss Meditec AG), applanation tonometry and slit-lamp 
evaluation including corneal status, cataract grading 
and fundus status with ophthalmoscopy. The cataract 
grading was based on a subjective assessment from zero 
to four performed by an experienced cataract surgeon: 
zero representing a clear lens and four representing a 
dark brown lens. Endothelial cell density and percentage 
of hexagonal cells were analysed using a non-contact 
specular microscope (SP 3000P; Topcon, Tokyo, Japan) 
with the Image-Net imaging system (V.4.0; Topcon). All 
patients underwent an ocular coherence tomography to 
exclude macular pathology and vitreomacular traction.
Postoperatively
The patients had a follow-up after 40 and 180 days at 
an optometrist blinded for operation technique. The 
following measurements were performed: uncorrected 
distance visual acuity (UDVA), CDVA with subjec-
tive refraction performed by an optometrist using an 
LCD visual acuity chart with equal logarithmic differ-
ence between the lines with decimal numbers for later 
possible conversion to logMAR values, autorefraction 
and endothelial imaging with endothelial cell density 
and hexagonality.
endothelial cell imaging
Preoperatively and at day 40 and 180, three photographs 
of each cornea were taken and analysed automatically 
by the Image-Net imaging system. Afterwards, a blinded 
observer chose the clearest image of the three and 
discarded the remaining two images. Hereafter, the cell 
count performed by Image-Net was manually corrected 
according to the golden standard.13 14
We calculated endothelial cell loss by:
Endothelial cell loss=Endothelial cell density
preopera-
tively
–Endothelial cell density
day
 
40
 
or
 
day
 
180
When calculating percentage endothelial cell loss, the 
following formula was used:
(Endothelial cell loss/Endothelial cell density
preopera-
tively
)×100
refractive outcome
Refractive outcomes were analysed using spherical equiv-
alent (SE) and the mean absolute error (MAE), which is 
the absolute difference between predicted and achieved 
postoperative SE refraction. We performed a subanalysis 
on patients with a preoperative refractive status of hyper-
opic eyes (>3 D), myopic eye (>6 D) and astigmatic eyes 
(>2 D), and we analysed our refractive results both with 
and without these patients.
ultrasound energy and fluid use
Infiniti Vision System (Alcon Laboratories, Fort Worth, 
Texas, USA) uses cumulative dissipated energy (CDE) 
as a value for phaco energy. This is calculated as (phaco 
time×average phaco power)+(torsional time×0.4×average 
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torsional amplitude). The factor 0.4 represents approx-
imate reduction of heat dissipated at the incision as 
compared with non-torsional phaco.
Fluid use was read from the Infiniti Vision System 
(Alcon Laboratories) after completed surgery.
randomisation
All patients had one eye randomly allocated by computer 
randomisation into either FLACS or CPS. Randomis-
ations were block randomisations performed by one 
clinician (TK) blinded from the operating order of the 
eyes. All randomisations were noted on a randomisa-
tion sheet. On surgery day, the surgeon would open the 
randomisation sheet and see what operation had to be 
performed. The other eye would receive the treatment 
not given to the randomised eye.
surgical technique
All patients were operated on by the same experienced 
cataract surgeon (AM). The eye with much worse vision 
was operated on first in order to forecast the second 
better-seeing eye from any possible complication. AM 
had performed more than 100 FLACS procedures before 
patient inclusion started.
FlACs
The laser (LensAR Laser System; LENSAR, Orlando, 
Florida, USA) procedure started with the docking of 
the laser with a 3D imaging of the anterior chamber, 
suggesting a treatment plan. Treatment plan and images 
were confirmed before the laser procedure. The laser 
performed a 5.0 mm capsulotomy and lens fragmenta-
tion. Lens fragmentation pattern was ‘piecut 6’ with three 
concentric circles. Hereafter, the laser was disconnected, 
and the remaining surgery was done as conventional 
phaco (CPS).
CPs
A 1 mm side port was created with a keratome followed 
by instillation of 0.5 mL lidocaine (10 mg/mL) and 
an ophthalmic viscosurgical device (Healon; Abbott 
Medical Optics, Santa Ana, California, USA). Then, a 
clear cornea main incision was fashioned with a 2.4 mm 
angled keratome. A continuous curvilinear capsulorhexis 
with an intended diameter of 5 mm was created (Utrata 
Forceps, Antony, France).
Phacoemulsification (Infiniti Vision System; Alcon 
Laboratories) and irrigation/aspiration (I/A) were 
performed using the technique ‘divide and conquer’. 
An aspheric, hydrophobic IOL (ZCB00; Abbott Medical 
Optics) was implanted using Healon, which was then 
aspirated. The procedure was concluded by instillation 
of 1 mL cefuroxime (2.5 mg/mL) and hydration of the 
incisions.
All statistical analyses were performed using R software 
(V.1.0.44). Baseline values were expressed as the mean 
with a 95% CI. Between-group comparative statistics were 
determined using a paired Student’s t-test or the Mann-
Whitney U test in case of non-parametric data. To evaluate 
visual outcome, all decimal values which came from an 
LCD visual acuity chart with equal logarithmic difference 
between the lines were transformed to logMAR values 
for the statistical analysis. Afterwards, logMAR values 
were back-transformed into Snellen values for easier 
reader-interpretation of the results. A univariate analysis 
with patients as random effects was used to evaluate the 
impact of operation variables on endothelial cell loss. 
Variables were operation method, phaco energy, fluid 
use, surgery time, preoperative endothelial cell density 
and cataract grade. Afterwards, a multivariate analysis of 
all variables with a significant outcome in the univariate 
was performed. P values of less than 0.05 were considered 
statistically significant. The sample size was calculated 
based on SD obtained in a previous study.9 This calcula-
tion resulted in 65 eyes per group, which was increased to 
108 to compensate for possible drop-outs.
Patient inclusion and exclusion
The study comprised 216 eyes of 108 patients (56 
women) with a postoperative follow-up of 180 days. The 
mean (±SD) number of days from operation to 40 days 
follow-up was 60±34 and the mean number of days from 
operation to 180 days follow-up was 234±124.
resulTs
Complications
In total, we had five cases with preoperative and post-
operative complications. These were equally distributed 
between the two groups (figure 1). We had one case 
without recognised preoperative risk factor who suffered 
nucleus loss and retinal detachment. This patient had 
FLACS and was excluded from the data analysis because 
the second eye was not operated on. In the remaining 
four cases with complications, the preoperative risk 
factors that we detected were as follows: (1) one CPS 
patient who used alpha-1-antagonist medicine and 
suffered capsule rupture—this patient cancelled the 
second eye surgery and was therefore excluded from the 
data analysis; (2) one FLACS patient suffered corneal 
oedema—this patient cancelled the second eye surgery 
and was, therefore, excluded from the data analysis; (3) 
one CPS patient suffered corneal oedema—this patient 
cancelled the second eye surgery and was, therefore, 
excluded from the data analysis; (4) one FLACS patient 
who had previous steroid treatment and suffered zonula 
rupture with sulcus implantation of the IOL—this patient 
had both eyes operated on and was included in the data 
analysis.
Preoperatively
In the FLACS eyes, there were 10 hyperopic (>3 D), 1 
myopic (>6 D) and 7 astigmatic patients (>2 D). In the 
CPS eyes, there were 13 hyperopic, 2 myopic and 6 astig-
matic patients. Therefore, the two groups had comparable 
preoperative refractive status. When pairing the eyes, the 
mean (±SD) preoperative difference in SE was −0.24±1.68 
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Table 2 Baseline characteristics of cataract grade and operation data: refractive and visual results
Surgery data (n=96)
FLACS (95% CI) CPS (95% CI)
P value
Paired t-test
Cataract grade 2.15 (2.04 to 2.27) 2.14 (2.03 to 2.26) 0.81
Energy CDE
(U/S)
6.55 (5.43 to 7.66) 9.77 (8.55 to 10.99) 1.29×10−7
Fluid use
(mL)
58.73 (54.79 to 62.66) 51.02 (47.55 to 54.49) 0.00015
Total procedure time (min) 9.66 (9.27 to 10.05) 7.05 (6.60 to 7.50) 5.95×10−15
Laser time
(min)
2.28 (2.21 to 2.35)
Knife time
(min)
7.38 (6.99 to 7.75) 7.05 (6.60 to 7.50) 0.265
Energy in the FLACS group was decreased by 33% compared with CPS. Laser time includes docking, suction and laser procedure. Total procedure 
time includes laser time and knife time.
CDE, cumulative dissipated energy; CPS, conventional phaco surgery; FLACS, femtosecond laser-assisted cataract surgery.
Figure 1 Display of patients included and follow-up. *Four patients with complications cancelled second eye surgery and 
failed to appear for follow-up. One of these patients had preoperative risk factors with alpha-1-antagonist treatment. This 
patient suffered from capsule rupture. Three patients with no preoperative known risk factor suffered from complications. 
Two patients suffered from corneal oedema and cancelled the next operation. One patient suffered nucleus loss and retinal 
detachment. All four patients cancelled the second eye surgery and were, therefore, excluded from the data analysis. FLACS, 
femtosecond laser-assisted cataract surgery.
D (95% CI −0.58 to 0.09). The cataract grade was compa-
rable between the two groups (table 2).
For MAE, we detected no significant difference between 
the two groups at day 40 or day 180 (table 3). This result 
remained non-significant after adjusting for preoperatively 
refractive status with hyperopic eyes (>3 D), myopic eyes 
(>6 D) and astigmatic eyes (>2 D) (table 3). At day 40, we 
found that 13.5% achieved attempted refraction (MAE=0) 
in FLACS compared with 10% in CPS, FLACS had 66% 
with an MAE less than 0.5 while CPS had 65%. At day 180, 
10% achieved attempted refraction in both FLACS and 
CPS. Fifty-six per cent of eyes treated by FLACS ended with 
an MAE of less than 0.5 D, compared with 64% treated by 
CPS.
At day 40, CPS had a significantly better UDVA than 
FLACS. UDVA at day 180 and CDVA at day 40 and day 
180 were not significantly different between the groups 
(table 4). In FLACS, 31% had UDVA ≥1.0 at day 40 
compared with 27% in CPS. At day 180, 30% of the FLACS 
eyes had UDVA ≥1.0 compared with 32% in the CPS group. 
At day 40, both FLACS and CPS had 71% with a CDVA ≥1.0. 
At day 180, FLACS had 75% with CDVA ≥1.0 while CPS had 
75% with CDVA ≥1.0.
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Table 3 Preoperative and postoperative values of SE and MAE
Preoperative and postoperative refractive results
Preoperatively (n=96)
Day 40 (n=88)
Day 180 (n=90)
FLACS (95% CI) CPS (95% CI) P value, paired t-test
Mean preoperative SE (D) 0.23 (−0.29 to 0.76) 0.19 (−0.40 to 0.78) 0.81
Mean SE day 40
(D)
−0.34 (−0.48 to 0.20) −0.37 (−0.50 to −0.24) 0.61
Mean MAE day 40
(D)
0.43 (0.36 to 0.51) 0.43 (0.36 to 0.51) 0.95
Mean SE day 180
(D)
−0.35 (−0.49 to −0.21) −0.36 (−0.51 to −0.21) 0.88
Mean MAE day 180 (D) 0.46 (0.39 to 0.53) 0.46 (0.37 to 0.52) 0.91
Mean MAE without subgroups day 180
(D)
0.44 (0.37 to 0.51) 0.42 (0.34 to 0.50) 0.68
Mean MAE without subgroups day 40
(D)
0.42 (0.34 to 0.50) 0.40 (0.33 to 0.47) 0.62
Mean MAE in subgroups day 180
(D)
0.45 (0.27 to 0.63) 0.44 (0.26 to 0.62) 0.94
Mean MAE in subgroups day 40
(D)
0.39 (950.23 to 0.54) 0.41 (0.26 to 0.56) 0.83
We analysed MAE with and without subgroups of hyperopia >3 D, myopia >6 D and astigmatism >2 D.
CPS, conventional phaco surgery; D, dioptre; FLACS, femtosecond laser-assisted cataract surgery; MAE, mean absolute error; SE, spherical 
equivalent.
Table 4 Visual outcome day 40 and day 180 in FLACS and CPS
Visual outcome day 40 and day 180
Day 40 (n=88)
Day 180 (n=90)
FLACS (95% CI) CPS (95% CI)
P value
Paired t-test
UDVA day 40 (Snellen) 0.62 (0.55 to 0.69) 0.67 (0.62 to 0.75) 0.03*
CDVA day 40 (Snellen) 0.97 (0.90 to 1.05) 0.98 (0.93 to 1.03) 0.71
UDVA day 180 (Snellen) 0.63 (0.56 to 0.71) 0.68 (0.62 to 0.75) 0.07
CDVA day 180 (Snellen) 0.98 (0.92 to 1.04) 0.99 (0.95 to 1.04) 0.63
*Statistically significant.
CDVA, corrected distance visual acuity; CPS, conventional phaco surgery; FLACS, femtosecond laser-assisted cataract surgery; UDVA, uncorrected 
distance visual acuity.
surgical results
CDE was significantly lower in FLACS compared with CPS. 
Comparing the two treatments, there was no statistically 
significant difference between knife time (see table 2); 
however, total procedure time (laser and knife time 
combined in FLACS vs knife time in CPS) was significantly 
longer in the FLACS eyes compared with the CPS eyes. 
There was a 15% significantly higher fluid use in FLACS 
compared with CPS.
endothelial cell results
The ECD and hexagonality were comparable between the 
two groups preoperatively. At day 40 and day 180, ECL was 
significantly lower in FLACS eyes compared with CPS eyes. 
Comparing the two groups, there was no statistically signif-
icant difference between hexagonality change at day 40 or 
day 180 (table 5).
Univariate analysis showed that CDE, preoperative endo-
thelial cell density, fluid use and operation method all 
had a significant effect on ECL. The multivariate analysis 
confirmed the significant correlation between ECL and 
CDE use as well as preoperative ECD; however, operation 
method and fluid use were insignificant in the multivariate 
analysis (table 6). We also performed another model where 
we divided CDE into different levels (0–5, 6–10, 11–20 and 
21–40 U/S) and examined what impact the different levels 
of CDE had on ECL (figure 2).
dIsCussIOn
The aim was to compare refractive predictability and 
endothelial cell loss in FLACS compared with CPS with 
a 6-month follow-up.
The timeframe for endothelial cell recovery is 1 to 180 
days.15 To evaluate the long-term effect of FLACS on the 
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Table 5 Preoperative and postoperative values of ECD, endothelial hexagonality and ECL in FLACS and CPS (ECL is also 
presented as percentages in parentheses)
Endothelial cell results
Preoperatively (n=93)
Day 40 (n=82)
Day 180 (n=85)
FLACS (95% CI) CPS (95% CI)
P value
Paired t-test
Mean preoperative ECD (cells/mm2) 2673 (2594 to 2752) 2734 (2684 to 2834) 0.073
Mean 40 days ECD (cells/mm2) 2326 (2205 to 2447) 2243 (2108 to 2377) 0.187
Mean 40 days ECL (cells/mm2) 344 (245 to 443)
(12.89%)
497 (380 to 614)
(18.19%)
0.027*
Mean 180 days ECD (cells/mm2) 2308 (2200 to 2416) 2256 (2140 to 2372) 0.244
Mean 180 days ECL (cells/mm2) 362 (275 to 450)
(13.56%)
465 (377 to 554)
(17.03%)
0.036*
Mean preop hexagonality (%) 55 (53 to 57) 55.4 (53 to 57) 0.95
Mean 40 days hexagonality (%) 50 (47 to 52) 53 (50 to 56) 0.09
Mean 40 days hexagonality change (%) 5.1 (2.0 to 8.1) 1.8 (–1.5 to 5.1) 0.18
Mean 180 days hexagonality (%) 55 (53 to 58) 53 (50 to 55) 0.112
Mean 180 days hexagonality change (%) −0.4 (−3.5 to 2.7) 2.0 (−0.6 to 4.6) 0.24
*Statistically significant.
CPS, conventional phaco surgery; ECD, endothelial cell density; ECL, endothelial cell loss; FLACS, femtosecond laser-assisted cataract surgery; 
Preop, preoperatively.
Table 6 Multivariate analysis
Multivariate analysis of patients with random effects
(n=86)
Coefficient (95% CI) P value
Multivariate analysis
ECL~CDE+fluid+operation method+preoperative ECD
CDE 36.2 (35.6 to 36.9) 1.319×10–12*
Preoperative ECD 0.193 (0.182 to 0.203) 0.0056*
Univariate analysis
Operation method 106 (98.14 to 113.74) 0.044*
Cataract grade I 376.5 (360.0 to 392.96) †
Cataract grade II 394.67 (377.3 to 415.0) 0.875
Cataract grade III 515.39 (495 to 535) 0.305
Cataract grade IIII 298.57 (256.86 to 340.28) 0.781
Surgery time 17.22 (15.39 to 19.04) 0.161
Preoperative endothelial cell density 0.21 (0.195 to 0.222) 0.023*
Fluid use 5.545 (5.29 to 5.80) 0.00163*
CDE 35.498 (34.8 to 36.1) 5.21×10–13*
We performed a multivariate analysis with patients with random effects to examine the impact of CDE, fluid use, operation method and preoperative 
ECD on ECL. We found that CDE is the main contributor to ECL and that preoperative ECD is significant for the amount of ECL. In the univariate 
model, we found that fluid use and operation method contribute to ECL.
*Statistically significant.
†Cataract grade I serves as a reference to the other cataract grades.
CDE, cumulative dissipated energy; CPS, conventional phaco surgery; ECD, endothelial cell density; ECL, endothelial cell loss; FLACS, femtosecond 
laser-assisted cataract surgery.
endothelium, we therefore measured endothelial cell 
loss at day 180. We detected a significant difference in 
ECL between FLACS and CPS at both day 40 and 180 
with a mean difference of 152 cells/mm2 (30% cell loss 
reduction in FLACS compared with CPS) at day 40 and 
103 cells/mm2 at day 180 (21% cell loss reduction in 
FLACS compared with CPS). A patient with a healthy 
endothelium can endure a cell loss of 100–160 cells/
mm2 without suffering from corneal oedema; however, 
for patients suffering from pre-existing endothelial 
cell loss, this amount of cell loss might cause corneal 
oedema.
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Figure 2 Mean endothelial cell loss at day 180 (cells/mm2) 
at different cumulative dissipated energy (CDE) levels. The 
figure demonstrates that the relationship between CDE 
and endothelial cell loss is non-linear and that there is less 
endothelial cell loss at lower CDE.
Figure 3 Correlation between cumulative dissipated energy 
(CDE) and endothelial cell loss (ECL) in femtosecond laser-
assisted cataract surgery (FLACS) and conventional phaco 
surgery (CPS). At day 180, the mean ECL was 326 cells/mm2 
in FLACS and 465 cells/mm2 in CPS. FLACS had greater 
ECL than CPS up to CDE energy levels of around 10 U/S.In CPS, there are ECL rapports between 1.4% and 
23%.8 16–19 Comparative studies between FLACS and CPS 
describes the ECL percentages as 5.8%–13.7% in the CPS 
group and 4.3%–17.06% in the FLACS group.9–12 20 21 Our 
findings with a difference in ECL percentages of 12.89%–
18.19% are in the high end of these findings.9–12 20 21 A 
problem when comparing ECL results in comparative 
studies is the heterogeneity in the cell counting tech-
nique. Validation studies report that the most reliable 
cell counts are obtained by choosing the clearest image, 
which is used for automated cell count performed by 
Image-Net and then manually correcting any incorrectly 
drawn cell borders.13 14 We used this technique. However, 
most studies examining ECL and FLACS do not mention 
how ECD are counted, which might explain the different 
ECL results found in other reports. Another problem 
with previous studies is that the majority of these are 
non-randomised studies with a short follow-up of about 
3 months making them inadequate to evaluate the long-
term effect. To our knowledge, none of the comparative 
studies between CPS and FLACs have examined endothe-
lial hexagonality. We saw an initial change of hexagonality 
at day 40 which was more profound in the FLACS group 
compared with CPS (5% vs 1.8% p>0.05). At day 180, 
the hexagonality change was normalised in FLACS while 
CPS reported a 2% hexagonality change (p>0.05). Our 
findings are in agreement with previous findings exam-
ining hexagonality after cataract surgery in patients with 
a healthy endothelium.8 16 19
When plotting the effect of different CDE levels on 
ECL (figure 2), we found that the relationship between 
ECL and CDE is non-linear, and CDE use above 10 U/S 
causes a doubling or more in ECL compared with CDE 
use below 10 U/S. In figure 3, ECL and the use of CDE in 
the two groups are plotted, showing that the initial ECL 
is higher in FLACS until a CDE level of approximately 
10 U/S, after which the curve flattens. This suggests that 
one can use up to 10 U/S of CDE in CPS without causing 
more cell loss than with FLACS. The higher amount of 
ECL at <10 U/S in FLACS compared with CPS suggests 
that factors other than CDE are involved in ECL. These 
other factors might be manual handling, turbulence, 
knife time and fluid use—in our study, we found that 
FLACS was associated with increased fluid use compared 
with CPS. This could be due to lens fragments that are 
not completely divided by FLACS compared with the 
cracking method used in CPS.
Our univariate analysis found that both fluid use and 
operation method were significant for ECL. Both vari-
ables became non-significant in the multivariate model 
(table 6), leaving only CDE and preoperatively ECD as 
significant for ECL. This indicates that the main contrib-
utor to ECL is CDE and operation method becomes 
non-significant as it is correlated to energy; thus, as 
FLACS uses less CDE than CPS, it has a lesser impact on 
the ECL.
In our study, we found a 33% decrease in CDE by FLACS. 
We used the operation method ‘divide and conquer’ and 
not chopping. The energy difference between CPS and 
FLACS would probably have been smaller if a chopping 
method had been used.8 However, we chose divide and 
conquer as this method was the preferred method by our 
experienced surgeon. Chopping technique can be more 
surgeon dependent and might lead to more manipula-
tion in the eye with more impact on the endothelium.8
We report five cases of complications: two cases in CPS 
eyes and three cases in FLACS eyes. The types of compli-
cations were different between the two groups but of 
equal severity. Four of the patients with complications 
cancelled their second eye surgery and, thus, were not 
included in the data analysis. Because the complications 
were equally distributed between the two groups, there 
was no skewness in the data.
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Figure 4 Comparison of postoperative MAE at 180 days 
after surgery between FLACS and CPS. Ten per cent 
achieved the attempted refraction in both FLACS and CPS. 
Fifty-six per cent treated by FLACS ended with an MAE 
of less than 0.5 D, compared with 64% treated by CPS. 
We detected no significant difference in CDVA or UDVA 
outcome between the two groups. CDVA, corrected distance 
visual acuity; CPS, conventional phaco surgery; FLACS, 
femtosecond laser-assisted cataract surgery; MAE, mean 
absolute error; UDVA, uncorrected distance visual acuity.
Figure 5 Achieved vs attempted refraction. Most eyes 
achieved an attempted refraction of zero spherical equivalent 
(SEQ). The circles below the line indicate that the eyes 
achieved a more myopic refraction than intended and vice 
versa. We found a subtle trend towards a more hyperopic 
refraction. CPS, conventional phaco surgery; FLACS, 
femtosecond laser-assisted cataract surgery.
FLACS produces a more centred circular capsulo-
tomy compared with CPS. A more precise capsulotomy 
would likely improve the position of the IOL and, thus, 
the predictability of the IOL power and the refractive 
results. We found no significant difference in MAE 
(table 3 and figure 4) even when adjusting for myopia, 
hyperopia and corneal astigmatism. These results 
concur with previous findings by other authors.3 22–24 
We found that our target refraction trended towards 
a more hyperopic refraction than intended (figure 5). 
In contrast to our findings, Conrad-Hengerer et al 
performed a randomised controlled trial examining 
refractive and visual outcome in 100 patients with 180 
days of follow-up.25 They found significant less MAE in 
FLACS (92% within 0.5 D) compared with CPS (71% 
within 0.5 D). This may be due to their exclusion of 
patients with high myopia, hyperopia or corneal astig-
matism of more than 1.5 D.
We detected a significantly better UDVA in the CPS group 
at day 40 compared with the FLACS group. However, this 
difference was non-significant at day 180. We detected no 
difference in CDVA between the two groups, at day 40 or 
day 180.
A possible explanation for the non-superior refractive 
results in FLACS could theoretically be that FLACS causes 
a more unstable capsulorhexis leading to more IOL decen-
tration and lens tilt. However, Panthier et al recently found 
that the mean diameter, mean deviation from intended 
rhexis size and mean deviation error were greater in CPS 
compared with FLACS a long with their finding with 
no significant differences in in UDVA, CDVA and MAE 
between the two groups.26
Mastropasqua et al and Toto et al examined lens 
decentration in the sagittal plane and both reported 
significantly less lens decentration in FLACS compared 
with CPS at day 180.3 24 In monofocal lenses, multiple 
reports state that decentration becomes clinically rele-
vant with a decentration of >0.4 mm.27 28 Mastropasqua et 
al and Toto et al found lens decentration in both CPS and 
FLACS to be less than the clinical relevant 0.4 mm.3 24
Limitations in our study is the lack of an objective or 
standardised subjective grading of the cataract grade 
preoperatively. This was not performed as cataract 
grading was not of primary concern instead we used 
energy consumption to evaluate ECL. We chose to use 
the patient as an intraindividual control and therefore 
randomised one eye leaving the other to get the opposite 
treatment than the randomised eye. It would have been 
possible to randomise all eyes instead of only one of the 
two eyes. We chose the former to reduce interindividual 
variation and because randomisation of all eyes would 
require inclusion of twice the number of eyes.
We included two follow-up controls. Follow-up at day 
40 was to examine refractive predictability not too long 
after surgery and follow-up at day 180 was to examine 
the long-term results of FLACS and CPS. However, it is 
possible that the interval between these two follow-ups are 
too long to detect a significance, and it would have been 
interesting to have a follow-up closer to the surgery date 
and after 3 months. We used the surgical technique ‘divide 
and conquer’, and we might have had different energy 
and ECL outcome if chopping technique had been used. 
Also, we used the LensAR Laser System (LENSAR) and 
Infiniti Vision System (Alcon Laboratories), and it would 
have been interesting to test a fluid-based interface system 
such as the Centurion Vision System (Alcon Laboratories). 
Furthermore, we did not measure IOL decentration or lens 
tilt.
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Our study is strengthened by its study design, which 
includes randomised choice of operation, a large 
patient cohort, use of a single experienced surgeon, 
counting of ECD by manually correcting the automated 
drawn cell borders by a blinded observer (as validation 
studies suggest), and blinded optometrist refraction 
performed at day 40 and day 180, as well as the use of 
the patients as their own control: one eye operated on 
by FLACS and the other eye by CPS.
COnClusIOn
We found that FLACS is associated with a 30% reduc-
tion in ECL at day 40 compared with CPS and a 21% 
reduction at day 180, with a mean difference in cell loss 
of 103–152 cells/mm2. These are promising results that 
could potentially benefit patients with pre-existing endo-
thelial cell loss. Future studies examining the impact of 
FLACS on the endothelium and its effect on corneal 
oedema in patients with pre-existing endothelial cell 
loss are needed. In our study, we detected no difference 
in refractive predictability nor visual outcome. At the 
moment, FLACS has yet to be shown to be advantageous 
compared with CPS in refractive clinical results.
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